Disease relevance of Pasteurella Infections

• Protection of rabbits against experimental pasteurellosis by a streptomycin-dependent Pasteurella multocida serotype 3:A live mutant vaccine [1].
• The capsular polysaccharide of P. haemolytica, therefore, may contribute in part to the fibrinous pleuropneumonia that characterizes acute pasteurellosis [2].
• Cellular immunity (T-cell subset using monoclonal antibody) in tuberculosis, melioidosis, pasteurellosis, penicilliosis; and role of levamisole and isoprinosine [3].

High impact information on Pasteurella Infections

• Sialic Acid metabolism and systemic pasteurellosis [4].
• A sialate aldolase (pm1715) mutant unable to initiate dissimilation of internalized sialic acid was not attenuated in the CD-1 mouse model of systemic pasteurellosis, indicating that the nutritional function of sialate catabolism is not required for systemic disease [4].
• Protection of rabbits against experimental pasteurellosis by vaccination with a potassium thiocyanate extract of Pasteurella multocida [5].
• Among these, a leukotoxin (LKT) and lipopolysaccharide (LPS) are thought to be the primary virulence factors that contribute to the characteristic pathology of pasteurellosis [6].
• CLINICAL RELEVANCE: Tilmicosin treatment of pasteurellosis in rabbits is useful in research rabbits and in those destined for meat production [7].

Chemical compound and disease context of Pasteurella Infections

• Use of long-acting oxytetracycline against pasteurellosis in lambs [8].
• Aztreonam protects mice against an aerogenic infection with highly virulent P multocida and may be useful in the prevention and treatment of pasteurellosis in cattle [9].
• Treatment of experimental pasteurellosis in lambs with clavulanic acid and amoxycillin [10].
• Serum cortisol levels in clinically normal feedlot lambs and clinicopathological features of septicemic pasteurellosis [11].
• Comparison of penicillin and gentamicin for treatment of pasteurellosis in rabbits [12].

References